期刊文献+

探讨多体素氢质子磁共振波谱在良恶性肌骨病变鉴别诊断中的价值 被引量:2

Primary investigation of the value of multi-voxel ~1H-MRS in differential diagnosis of benign and malignant mnsculoskeletal lesions of limbs
原文传递
导出
摘要 目的探讨多体素氢质子 MR 波谱(~1H-MRS)在鉴别良恶性肌骨病变方面的应用价值。方法搜集经病理证实的骨与软组织良恶性病变患者47例,男28例,女19例。良性病变9例,恶性病变38例。所有病例在~1H-MRS 检查前均行动态和延迟增强扫描。统计动态增强扫描中 MR 信号强度-时间(SI-T)曲线最大线性斜率(5.09)鉴别良恶性病变的敏感度、特异度和准确度。将~1H-MRS 谱线分为2型:Ⅰ型,谱线中3.2 ppm(×10^(-6))处有明显的胆碱(Cho)峰;Ⅱ型,谱线中3.2 ppm处无明显的 Cho 峰。统计良恶性病变出现2种谱线的例数,并计算诊断良恶性病变的敏感度、特异度和准确度。结果 9例良性病变的 SI-T 曲线最大线性斜率范围为0.07~8.54,平均为3.48±2.30。38例恶性病变最大线性斜率范围为2.89~32.50,平均9.56±5.16,以5.09作为 SI-T 曲线最大斜率的良恶性病变界值时,诊断的敏感度为97.30%,特异度为80.00%,准确度为93.62%。47例中有42例多体素~1H-MRS 效果满意,9例良性病变中出现Ⅰ型谱线2例,Ⅱ型谱线7例;33例恶性肿瘤中出现Ⅰ型谱线27例,Ⅱ型谱线6例,良恶性谱线类型例数比较,χ~2=9.13,P<0.01。Ⅰ型谱线诊断恶性肿瘤的敏感度为93.10%,特异度为53.80%,准确度为80.95%;若不计钙化、骨化成分较多的6例,则敏感度为93.10%,特异度为100%,准确度为94.44%。结论 ~1H-MRS谱线的类型对评价肌骨病变的生物学活性价值较高,对钙化和骨化较少的病变良恶性的鉴别效果与 MR 动态增强扫描的效果相当。 Objective To investigate the value of ^1H-MRS in differential diagnosis of benign from malignant musculoskeletal lesions primarily. Methods Forty-seven patients including 28 males and 19 females with bone and soft tissue lesions (9 benign and 38 malignant) were researched. All patients were performed MR dynamic and delay enhancement scan before ^1H-MRS. Diagnostic sensitivity, specificity and accuracy of maximal slope value 5.09 of SI-T curves in differential diagnosis of benign and malignant were calculated . Two types of ^1H-MRS curves were found, there was identifiable choline apex at 3. 2ppm in Type Ⅰ , and no obvious choline apex at the same position in Type Ⅱ , X^2 test was performed between the number of benign and malignant lesions. Results The average maximal slope value ± Std. deviation of 9 benign lesions was 3.48 ± 2. 30, range 0. 07-8. 54, the average maximal slope value ± Std. deviation of 38 malignant lesions was 9. 56 ± 5. 16, range 2. 89-32. 50. With maximal slope value 5.09 as the threshold of malignant in MR dynamic enhancement, the diagnostic sensitivity was 97. 30%, specificity was 80.00% and accuracy was 93.62%. 42 of the 47 eases acquired satisfactory ^1 H-MRS. Type Ⅰ ^1 H-MRS was found in 2 benign and 27 malignant, and type Ⅱ ^1 H-MRS was found in 7 benign and 6 malignant. Numbers of different type of ^1H-MRS was compared between benign and malignant, X^2 =9. 13 P 〈0. 01. Making Type Ⅰ ^1H-MRS curve as standard of malignant, the sensitivity was 93.10%, specificity was 53. 80% and accuracy was 80. 95%. If the 6 lesions with much ealeiiieation or ossification were excluded, the sensitivity,specificity and accuracy became 93. 10%, 100% and 94. 44%. Conclusion Type of ^1 H-MRS was valuable for identifying biological activity of musculoskeletal lesions. For lesions with little or no calcification or ossification, the differential effect of benign from malignant was correspond to that of MR dynamic enhancement.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2007年第3期264-268,共5页 Chinese Journal of Radiology
关键词 骨肿瘤 软组织肿瘤 磁共振波谱学 诊断 鉴别 Bone neoplasm Soft tissue neoplasm Magnetic resonance spectroscopy Diagnosis, differential
  • 相关文献

参考文献15

  • 1郁万江,杜湘珂.动态多层面MR T1W灌注成像鉴别良恶性肌骨病变[J].中国医学影像技术,2005,21(6):937-940. 被引量:8
  • 2Wang CK, Li CW, Hsieh TJ, et al. Characterization of bone and soft-tissue tumors with in vivo ^1H MR spectroscopy: initial results.Radiology, 2004, 232: 599 -605.
  • 3Oya N, Aoki J, Shinozaki, et al. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors:an unassigned signal at 2. 0-2. 1 ppm may be a possible indicator of malignant neuroectodermal tumor. Radiat Med, 2000, 18:193-198.
  • 4周春香,孟悛非,陈应明,罗柏宁,张中伟.磁共振氢质子波谱在下肢骨-软组织疾病中应用初探[J].临床放射学杂志,2003,22(12):1035-1038. 被引量:12
  • 5Negendank W. Studies of human tumors by MRS: a review (Review). NMR Biomed, 1992,5:303-324.
  • 6Ruiz-Cabello J, Cohen JS. Phospholipid metabolites as indicators of cancer cell function. NMR Biomed, 1992, 5:226-233.
  • 7Kurhanewicz J, Vigneron DB, Hricak H, et al. Three-dimensional H-1 MR spectroscopic imaging of the human prostate with high spatial resolution. Radiology, 1996, 198:795-805.
  • 8Yeung DK, Cheung HS, Tse GM. Human breast lesions:characterization with contrast-enhanced in vivo proton MR spectroscopy-initial results. Radiology, 2001,220:40-46.
  • 9Allen JR, Prost RW, Griffith OW, et al. In vivo proton H^1 magnetic resonance spectroscopy for cervical carcinoma. Am J Clin Oncol, 2001,24:522-529.
  • 10王霄英,周良平,丁建平,山刚志,蒋学祥.前列腺癌的MR波谱定量分析:与系统穿刺活检病理对照研究[J].中华放射学杂志,2004,38(3):268-272. 被引量:85

二级参考文献30

  • 1赵京龙,张贵祥.动态增强MR成像在肿瘤血管生成功能成像中的应用[J].中国医学影像技术,2004,20(8):1293-1295. 被引量:7
  • 2王继琛,高玉洁,蒋学祥,李松年,刘赓年.前列腺癌的MRI诊断与分期[J].中华放射学杂志,1996,30(11):741-744. 被引量:28
  • 3[7]Schick F, Duda S, Laniado M, et al. Special MR methods for primary bone tumors: Ⅱ. Volume selective 1 H-spectroscopy. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr, 1993, 159:325
  • 4[8]Joseph R, Kim MC, Mitchell DS, et al. Human breast lesions: characterization with proton. MR spectroscopy. Radiology, 1998, 209:269
  • 5[10]Wang Z, Zimmerman RA, Sauter R. Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR, 1996, 167:191
  • 6[11]Lin CS, Fertikh D, Davis D, et al. 2D CSI proton MR spectroscopy of human spinal vertebra: feasibility studies. J Magn Reson Imaging, 2000, 11:287
  • 7[12]Negendank W. Studies of human tumors by MRS. NMR Biomed, 1992, 5:303
  • 8[1]Schellinger D, Lin CS, Hatipoglu HG,et al. Potential value of vertebral proton MR spectroscopy in determining bone weakness. AJNR, 2001, 22:1620
  • 9[2]Schellinger D, Lin CS, Fertikh D, et al. Normal lumbar vertebrae: anatomic, age, and sex variance in subjects at proton MR spectroscopy-initial experience. Radiology, 2000, 215:910
  • 10[3]Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR, 1996, 17:1

共引文献146

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部